Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Cytosorbents (CTSO) Return on Invested Capital (2016 - 2025)

Cytosorbents' Return on Invested Capital history spans 13 years, with the latest figure at 0.1% for Q4 2025.

  • Quarterly results put Return on Invested Capital at 0.1% for Q4 2025, up 92.0% from a year ago — trailing twelve months through Dec 2025 was 0.1% (up 92.0% YoY), and the annual figure for FY2025 was 0.2%, up 50.0%.
  • Return on Invested Capital for Q4 2025 was 0.1% at Cytosorbents, up from 0.54% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 0.1% in Q4 2025 to a low of 2.24% in Q3 2024.
  • The 5-year median for Return on Invested Capital is 0.69% (2022), against an average of 0.68%.
  • The sharpest move saw Return on Invested Capital tumbled -123bps in 2024, then soared 170bps in 2025.
  • Year by year, Return on Invested Capital stood at 0.33% in 2021, then plummeted by -147bps to 0.82% in 2022, then fell by -12bps to 0.91% in 2023, then decreased by -12bps to 1.02% in 2024, then skyrocketed by 90bps to 0.1% in 2025.
  • According to Business Quant data, Return on Invested Capital over the past three periods came in at 0.1%, 0.54%, and 0.87% for Q4 2025, Q3 2025, and Q1 2025 respectively.